|Anti-IL5 therapy for asthma and beyond|
M Mukherjee, R Sehmi, P Nair
World Allergy Organization Journal 7 (1), 1-15, 2014
|Weight-adjusted intravenous reslizumab in severe asthma with inadequate response to fixed-dose subcutaneous mepolizumab|
M Mukherjee, F Aleman Paramo, M Kjarsgaard, B Salter, G Nair, ...
American journal of respiratory and critical care medicine 197 (1), 38-46, 2018
|Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma|
SG Smith, A Gugilla, M Mukherjee, K Merim, A Irshad, W Tang, ...
Journal of Allergy and Clinical Immunology 135 (6), 1594-1602, 2015
|Sputum autoantibodies in patients with severe eosinophilic asthma|
M Mukherjee, DC Bulir, K Radford, M Kjarsgaard, CM Huang, ...
Journal of Allergy and Clinical Immunology 141 (4), 1269-1279, 2018
|Evaluation of air-interfaced Calu-3 cell layers for investigation of inhaled drug interactions with organic cation transporters in vitro|
M Mukherjee, DI Pritchard, C Bosquillon
International journal of pharmaceutics 426 (1-2), 7-14, 2012
|Blood or sputum eosinophils to guide asthma therapy?|
M Mukherjee, P Nair
The Lancet Respiratory Medicine 11 (3), 824-825, 2015
|Benralizumab attenuates airway eosinophilia in prednisone-dependent asthma|
R Sehmi, HF Lim, M Mukherjee, C Huang, K Radford, P Newbold, ...
Journal of Allergy and Clinical Immunology 141 (4), 1529-1532. e8, 2018
|Autoimmune responses in severe asthma|
M Mukherjee, P Nair
Allergy, asthma & immunology research 10 (5), 428-447, 2018
|Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy|
M Mukherjee, HF Lim, S Thomas, D Miller, M Kjarsgaard, B Tan, R Sehmi, ...
Allergy, Asthma & Clinical Immunology 13 (1), 2, 2017
|Eosinophil Extracellular Traps and Inflammatory Pathologies—Untangling the Web!|
M Mukherjee, P Lacy, S Ueki
Frontiers in Immunology 9, 2763, 2018
|Glucocortiosteroid subsensitivity and asthma severity|
M Mukherjee, S Svenningsen, P Nair
Current opinion in pulmonary medicine 23 (1), 78-88, 2017
|CT and functional MRI to evaluate airway mucus in severe asthma|
S Svenningsen, E Haider, C Boylan, M Mukherjee, RL Eddy, DPI Capaldi, ...
Chest 155 (6), 1178-1189, 2019
|Human Bronchial Epithelial Cell–derived Factors from Severe Asthmatic Subjects Stimulate Eosinophil Differentiation|
BMA Salter, SG Smith, M Mukherjee, S Plante, S Krisna, G Nusca, ...
American journal of respiratory cell and molecular biology 58 (1), 99-106, 2018
|Sputum antineutrophil cytoplasmic antibodies in serum antineutrophil cytoplasmic antibody–negative eosinophilic granulomatosis with polyangiitis|
M Mukherjee, SR Thomas, K Radford, A Dvorkin-Gheva, S Davydchenko, ...
American journal of respiratory and critical care medicine 199 (2), 158-170, 2019
|Improved recovery of functionally active eosinophils and neutrophils using novel immunomagnetic technology|
K Son, M Mukherjee, BAS McIntyre, JC Eguez, K Radford, N LaVigne, ...
Journal of Immunological Methods 449, 44-55, 2017
|Airway eosinophilopoietic and autoimmune mechanisms of eosinophilia in severe asthma|
A Bhalla, M Mukherjee, P Nair
Immunology and Allergy Clinics 38 (4), 639-654, 2018
|In-cell Western™ detection of organic cation transporters in bronchial epithelial cell layers cultured at an air–liquid interface on TranswellŽ inserts|
M Mukherjee, ML Latif, DI Pritchard, C Bosquillon
Journal of Pharmacological and Toxicological Methods 68 (2), 184-189, 2013
|Sub-optimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena|
M Mukherjee, DF Forero, S Tran, ME Boulay, M Bertrand, A Bhalla, ...
European Respiratory Journal, 2020
|Eosinophil-derived IL-13 promotes emphysema|
AD Doyle, M Mukherjee, WE LeSuer, TB Bittner, SM Pasha, JJ Frere, ...
European Respiratory Journal 53 (5), 1801291, 2019
|New paradigm in asthma management: Switching between biologics!|
M Mukherjee, P Bakakos, S Loukides